249 related articles for article (PubMed ID: 16983118)
1. Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms.
Wang XS; Fairclough DL; Liao Z; Komaki R; Chang JY; Mobley GM; Cleeland CS
J Clin Oncol; 2006 Sep; 24(27):4485-91. PubMed ID: 16983118
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy.
Wang XS; Shi Q; Williams LA; Mao L; Cleeland CS; Komaki RR; Mobley GM; Liao Z
Brain Behav Immun; 2010 Aug; 24(6):968-74. PubMed ID: 20353817
[TBL] [Abstract][Full Text] [Related]
3. Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy.
Wang XS; Williams LA; Krishnan S; Liao Z; Liu P; Mao L; Shi Q; Mobley GM; Woodruff JF; Cleeland CS
Brain Behav Immun; 2012 Jul; 26(5):699-705. PubMed ID: 22251605
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC).
Jain AK; Hughes RS; Sandler AB; Dowlati A; Schwartzberg LS; Dobbs T; Schlabach L; Wu J; Muldowney NJ; Choy H
J Thorac Oncol; 2009 Jun; 4(6):722-7. PubMed ID: 19404213
[TBL] [Abstract][Full Text] [Related]
5. Prospective Study of Patient-Reported Symptom Burden in Patients With Non-Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy.
Wang XS; Shi Q; Williams LA; Komaki R; Gomez DR; Lin SH; Chang JY; O'Reilly MS; Bokhari RH; Cox JD; Mohan R; Cleeland CS; Liao Z
J Pain Symptom Manage; 2016 May; 51(5):832-8. PubMed ID: 26891607
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
Feigenberg SJ; Hanlon AL; Langer C; Goldberg M; Nicolaou N; Millenson M; Coia LR; Lanciano R; Movsas B
J Thorac Oncol; 2007 Apr; 2(4):287-92. PubMed ID: 17409799
[TBL] [Abstract][Full Text] [Related]
9. Concomitant chemoradiotherapy using pemetrexed and carboplatin for unresectable stage III non-small cell lung cancer (NSCLC): preliminary results of a phase II study.
Xu Y; Ma S; Ji Y; Sun X; Jiang H; Chen J; Du X; Zheng Y; Qiu G
Lung Cancer; 2011 Jun; 72(3):327-32. PubMed ID: 21056507
[TBL] [Abstract][Full Text] [Related]
10. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
Pallarés C; Capdevila J; Paredes A; Farré N; Ciria JP; Membrive I; Basterrechea L; Gomez-Segura G; Barnadas A
Lung Cancer; 2007 Nov; 58(2):238-45. PubMed ID: 17658655
[TBL] [Abstract][Full Text] [Related]
11. How to improve loco-regional control in stages IIIa-b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group.
Nyman J; Friesland S; Hallqvist A; Seke M; Bergström S; Thaning L; Lödén B; Sederholm C; Wagenius G
Lung Cancer; 2009 Jul; 65(1):62-7. PubMed ID: 19081652
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of concurrent real-time tumor-tracking thoracic radiation therapy with paclitaxel and carboplatin in locally advanced non-small cell lung cancer.
Sakakibara-Konishi J; Oizumi S; Kinoshita I; Shinagawa N; Kikuchi J; Kato M; Inoue T; Katoh N; Onimaru R; Shirato H; Dosaka-Akita H; Nishimura M
Lung Cancer; 2011 Nov; 74(2):248-52. PubMed ID: 21397973
[TBL] [Abstract][Full Text] [Related]
13. The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected locally advanced non-small cell lung cancer.
Sun HB; Wang SY; Ou W; Zhang BB; Yang H; Fang Q
Lung Cancer; 2010 Jun; 68(3):403-8. PubMed ID: 19913325
[TBL] [Abstract][Full Text] [Related]
14. Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory.
Fagundes CP; Shi Q; Vaporciyan AA; Rice DC; Popat KU; Cleeland CS; Wang XS
J Thorac Cardiovasc Surg; 2015 Sep; 150(3):613-9.e2. PubMed ID: 26088408
[TBL] [Abstract][Full Text] [Related]
15. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N
J BUON; 2007; 12(1):33-9. PubMed ID: 17436399
[TBL] [Abstract][Full Text] [Related]
16. The relationship between symptom severity and symptom interference, education, age, marital status, and type of chemotherapy treatment in Israeli women with early-stage breast cancer.
Prigozin A; Uziely B; Musgrave CF
Oncol Nurs Forum; 2010 Nov; 37(6):E411-8. PubMed ID: 21059574
[TBL] [Abstract][Full Text] [Related]
17. Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
Sarna L; Swann S; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Byhardt R; Wasserman T; Movsas B
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1378-84. PubMed ID: 18501528
[TBL] [Abstract][Full Text] [Related]
18. Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab--pooled results from two prospective clinical trials.
Hallqvist A; Bergman B; Nyman J
Radiother Oncol; 2012 Jul; 104(1):39-44. PubMed ID: 22727262
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
Davies AM; Chansky K; Lau DH; Leigh BR; Gaspar LE; Weiss GR; Wozniak AJ; Crowley JJ; Gandara DR;
J Clin Oncol; 2006 Nov; 24(33):5242-6. PubMed ID: 17114656
[TBL] [Abstract][Full Text] [Related]
20. The effect of radiation dose and chemotherapy on overall survival in 237 patients with Stage III non-small-cell lung cancer.
Wang L; Correa CR; Zhao L; Hayman J; Kalemkerian GP; Lyons S; Cease K; Brenner D; Kong FM
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1383-90. PubMed ID: 18929449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
